FDA
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on LifeMD Inc (LFMD)
-
-
-
-
-
-
-
LifeMD Offers OzempicĀ® at $499 Per Month through Collaboration with Novo Nordisk
-
-
-
-
-
-
-
LifeMD, Inc. (LFMD) Announces Integration with LillyDirect Pharmacy Provider to Offer Patients Streamlined Access to Branded Dual GLP-1/GIP Zepbound
-
-
-
-
-
-
-
LifeMD Elevates Successful GLP-1 Weight Management Program with Proprietary Platform Enhancements
-
-
-
-
-
-
-
LifeMD Reports Fourth Quarter and Full Year 2021 Results
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Intrusion, LifeMD, Romeo Power, and Acadia Pharmaceuticals and Encourages Investors to Contact the Firm
-
-
328,386 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

